Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "N04BA" (67)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Levodopa and Decarboxylase Inhibitor (N04BA02) 30 products
WHO-DDD
DrugBank.ca
IP
CI
Madopar 62.5
-
T
100 Capsule(s)
8.48
18.30
10 %
Capsules: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Madopar 125
100 Capsule(s)
11.01
28.35
10 %
Capsules: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Madopar 125
-
T
30 Tablet(s)
3.90
13.45
10 %
Tablets: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Madopar 125
-
T
100 Tablet(s)
11.01
28.35
10 %
Tablets: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Madopar 250
-
T
30 Tablet(s)
8.76
18.60
10 %
Tablets: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Madopar 250
-
T
100 Tablet(s)
26.64
44.90
10 %
Tablets: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Carbidopa/Levodopa Sandoz CR
25/100
-
T
30 Tablet(s)
4.59
14.25
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Carbidopa/Levodopa Sandoz CR
25/100
-
T
100 Tablet(s)
12.94
30.50
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Carbidopa/Levodopa Sandoz CR
50/200
-
T
30 Tablet(s)
8.52
25.70
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Carbidopa/Levodopa Sandoz CR
50/200
-
T
100 Tablet(s)
26.51
45.25
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Levodopa / Benserazid
Devatis 62.5 mg (50 mg +
12.5 mg)
100
5.94
15.70
10 %
Tablets: 2 Active Agents
Devatis AG
B / SL / SG
FB
G
IP
Levodopa / Benserazid
Devatis 125 mg (100 mg + 25 mg)
30
3.55
13.10
10 %
Tablets: 2 Active Agents
Devatis AG
B / SL / SG
FB
G
IP
Levodopa / Benserazid
Devatis 125 mg (100 mg + 25 mg)
100
10.01
27.30
10 %
Tablets: 2 Active Agents
Devatis AG
B / SL / SG
FB
G
IP
Levodopa / Benserazid
Devatis 250 mg (200 mg + 50 mg)
30
6.13
15.90
10 %
Tablets: 2 Active Agents
Devatis AG
B / SL / SG
FB
G
IP
Levodopa / Benserazid
Devatis 250 mg (200 mg + 50 mg)
100
18.65
36.70
10 %
Tablets: 2 Active Agents
Devatis AG
B / SL / SG
FB
G
IP
CI
Madopar DR
30 Tablet(s)
17.19
35.10
10 %
Tablets: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL
FB
G
IP
CI
Madopar DR
100 Tablet(s)
53.64
74.75
10 %
Tablets: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL
FB
G
IP
CI
Sinemet 25/100 mg
30
5.23
14.90
10 %
Tablets: 2 Active Agents
Organon GmbH
B / SL
FB
G
IP
CI
Sinemet 25/100 mg
100
15.02
32.75
10 %
Tablets: 2 Active Agents
Organon GmbH
B / SL
FB
G
IP
CI
Sinemet 25/250 mg
30
7.19
17.05
10 %
Tablets: 2 Active Agents
Organon GmbH
B / SL
FB
G
IP
CI
Sinemet 25/250 mg
100
22.43
40.80
10 %
Tablets: 2 Active Agents
Organon GmbH
B / SL
FB
G
L
IP
CI
Duodopa
7 Sachet(s)
405.36
457.25
10 %
Gel for intestinal application: 2 Active Agents
AbbVie AG
B / SL
FB
G
IP
CI
Madopar LIQ 62.5
100 Tablet(s)
8.48
25.65
10 %
Tabletten zur Herstellung einer Suspension zum Einnehmen: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL
FB
G
IP
CI
Madopar LIQ 125
-
T
30 Tablet(s)
5.07
14.75
10 %
Tabletten zur Herstellung einer Suspension zum Einnehmen: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL
FB
G
IP
CI
Madopar LIQ 125
-
T
100 Tablet(s)
14.30
31.95
10 %
Tabletten zur Herstellung einer Suspension zum Einnehmen: 2 Active Agents
Roche Pharma
(Schweiz) AG
B / SL
FB
G
IP
CI
Levacin 100/25
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
Levacin 100/25
100
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
Levacin 200/50
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
Levacin 200/50
100
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
Levodopa / Benserazid
Devatis 62.5 mg (50 mg +
12.5 mg)
30
1.78
6.65
k.A.
Tablets: 2 Active Agents
Devatis AG
B
FB
G
Levodopa, Decarboxylase Inhibitor and Comt Inhibitor (N04BA03) 37 products
WHO-DDD
DrugBank.ca
IP
CI
Stalevo 50/12.5/200 mg
-
T
30 Tablet(s)
20.15
38.15
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 50/12.5/200 mg
-
T
100 Tablet(s)
63.37
84.75
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 75/18.75/200 mg
30 Tablet(s)
21.07
39.15
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 75/18.75/200 mg
100 Tablet(s)
65.89
87.45
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 100/25/200 mg
-
T
30 Tablet(s)
21.99
40.15
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 100/25/200 mg
-
T
100 Tablet(s)
68.41
90.20
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 125/31.25/200 mg
30 Tablet(s)
22.78
41.00
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 125/31.25/200 mg
100 Tablet(s)
70.54
92.50
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 150/37.5/200 mg
-
T
30 Tablet(s)
23.56
41.80
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 150/37.5/200 mg
-
T
100 Tablet(s)
72.65
94.75
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 200/50/200 mg
30 Tablet(s)
25.25
43.65
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 200/50/200 mg
100 Tablet(s)
77.15
99.60
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Lecapon-Mepha 50 mg /
12.5 mg / 200 mg
30 Tablet(s)
17.13
35.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 50 mg /
12.5 mg / 200 mg
100 Tablet(s)
53.88
75.00
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 75 mg /
18.75 mg / 200 mg
30 Tablet(s)
17.91
35.90
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 75 mg /
18.75 mg / 200 mg
100 Tablet(s)
56.02
77.35
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 100 mg / 25 mg / 200 mg
30 Tablet(s)
18.70
36.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 100 mg / 25 mg / 200 mg
100 Tablet(s)
58.16
79.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 125 mg /
31.25 mg / 200 mg
30 Tablet(s)
19.36
37.45
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 125 mg /
31.25 mg / 200 mg
100 Tablet(s)
59.97
81.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 150 mg /
37.5 mg / 200 mg
30 Tablet(s)
20.03
38.20
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 150 mg /
37.5 mg / 200 mg
100 Tablet(s)
61.76
83.60
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 200 mg / 50 mg / 200 mg
30 Tablet(s)
21.47
39.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 200 mg / 50 mg / 200 mg
100 Tablet(s)
65.58
87.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecigon
7 x 47 ml
PR
PR
k.A.
Gel for intestinal application: 3 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
50/12.5/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
50/12.5/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
75/18.75/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
75/18.75/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
100/25/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
100/25/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
125/31.25/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
125/31.25/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
150/37.5/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
150/37.5/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
200/50/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
200/50/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home